Product References
Exosome proteomics study of the effects of traditional cigarettes and electronic cigarettes on human bronchial epithelial cells.
Toxicology in vitro : an international journal published in association with BIBRA
Wang W,Zeng R,Liu M,Chen M,Wei S,Li B,Yu S
Wed Feb 01 00:00:00 EST 2023
Age and oxidative stress regulate Nrf2 homeostasis in human articular chondrocytes.
Osteoarthritis and cartilage
Taylor EL,Collins JA,Gopalakrishnan P,Chubinskaya S,Loeser RF
Fri Sep 01 00:00:00 EDT 2023
Sulfiredoxin Promotes Cancer Cell Invasion through Regulation of the miR143-Fascin Axis.
Molecular and cellular biology
Jiang H,Thapa P,Ding N,Hao Y,Alshahrani A,Wang C,Evers BM,Wei Q
Thu May 19 00:00:00 EDT 2022
Bioinformatics-Driven Identification of p62 as A Crucial Oncogene in Liver Cancer.
Frontiers in oncology
Wang L,Hensley CR,Howell ME,Ning S
Sat May 06 00:00:00 EDT 2023
Apigenin Induced Apoptosis by Downregulating Sulfiredoxin Expression in Cutaneous Squamous Cell Carcinoma.
Oxidative medicine and cellular longevity
Wang W,Liu X,Zhang Z,Yin M,Chen X,Zhao S,Wu L
Tue Aug 16 00:00:00 EDT 2022
Apigenin Induced Apoptosis by Downregulating Sulfiredoxin Expression in Cutaneous Squamous Cell Carcinoma.
Oxidative medicine and cellular longevity
Wang W,Liu X,Zhang Z,Yin M,Chen X,Zhao S,Wu L
Tue Aug 16 00:00:00 EDT 2022
Apigenin Induced Apoptosis by Downregulating Sulfiredoxin Expression in Cutaneous Squamous Cell Carcinoma.
Oxidative medicine and cellular longevity
Wang W,Liu X,Zhang Z,Yin M,Chen X,Zhao S,Wu L
Tue Aug 16 00:00:00 EDT 2022
Apigenin Induced Apoptosis by Downregulating Sulfiredoxin Expression in Cutaneous Squamous Cell Carcinoma.
Oxidative medicine and cellular longevity
Wang W,Liu X,Zhang Z,Yin M,Chen X,Zhao S,Wu L
Tue Aug 16 00:00:00 EDT 2022
Mechanistic Analysis of an Extracellular Signal-Regulated Kinase 2-Interacting Compound that Inhibits Mutant BRAF-Expressing Melanoma Cells by Inducing Oxidative Stress.
The Journal of pharmacology and experimental therapeutics
Martinez R,Huang W,Samadani R,Mackowiak B,Centola G,Chen L,Conlon IL,Hom K,Kane MA,Fletcher S,Shapiro P
Fri Jan 01 00:00:00 EST 2021
N-Acetylcysteine Reduces the Pro-Oxidant and Inflammatory Responses during Pancreatitis and Pancreas Tumorigenesis.
Antioxidants (Basel, Switzerland)
Minati MA,Libert M,Dahou H,Jacquemin P,Assi M
Sun Jul 11 00:00:00 EDT 2021
Sulfiredoxin-1 protects retinal ganglion cells from high glucose-induced oxidative stress and inflammatory injury by potentiating Nrf2 signaling via the Akt/GSK-3β pathway.
International immunopharmacology
Zhu F,Shao J,Tian Y,Xu Z
Wed Dec 01 00:00:00 EST 2021
Sulfiredoxin-1 is a promising novel prognostic biomarker for hepatocellular carcinoma.
Cancer medicine
Rao QW,Zhang SL,Guo MZ,Yuan FF,Sun JL,Qi F,Wang LS,Yang BW,Xia JL
Sun Nov 01 00:00:00 EDT 2020
Sulfiredoxin-1 is a promising novel prognostic biomarker for hepatocellular carcinoma.
Cancer medicine
Rao QW,Zhang SL,Guo MZ,Yuan FF,Sun JL,Qi F,Wang LS,Yang BW,Xia JL
Sun Nov 01 00:00:00 EDT 2020
SRXN1 stimulates hepatocellular carcinoma tumorigenesis and metastasis through modulating ROS/p65/BTG2 signalling.
Journal of cellular and molecular medicine
Lv X,Yu H,Zhang Q,Huang Q,Hong X,Yu T,Lan H,Mei C,Zhang W,Luo H,Pang P,Shan H
Tue Sep 01 00:00:00 EDT 2020
The redox regulator sulfiredoxin forms a complex with thioredoxin domain-containing 5 protein in response to ER stress in lung cancer cells.
The Journal of biological chemistry
Chawsheen HA,Jiang H,Ying Q,Ding N,Thapa P,Wei Q
Fri May 31 00:00:00 EDT 2019
Enhanced SIRT6 activity abrogates the neurotoxic phenotype of astrocytes expressing ALS-linked mutant SOD1.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology
Harlan BA,Pehar M,Killoy KM,Vargas MR
Sat Jun 01 00:00:00 EDT 2019
Nrf2-activated expression of sulfiredoxin contributes to urethane-induced lung tumorigenesis.
Cancer letters
Mishra M,Jiang H,Chawsheen HA,Gerard M,Toledano MB,Wei Q
Fri Sep 28 00:00:00 EDT 2018
Nrf2-activated expression of sulfiredoxin contributes to urethane-induced lung tumorigenesis.
Cancer letters
Mishra M,Jiang H,Chawsheen HA,Gerard M,Toledano MB,Wei Q
Fri Sep 28 00:00:00 EDT 2018
Nrf2-activated expression of sulfiredoxin contributes to urethane-induced lung tumorigenesis.
Cancer letters
Mishra M,Jiang H,Chawsheen HA,Gerard M,Toledano MB,Wei Q
Fri Sep 28 00:00:00 EDT 2018
Nrf2-activated expression of sulfiredoxin contributes to urethane-induced lung tumorigenesis.
Cancer letters
Mishra M,Jiang H,Chawsheen HA,Gerard M,Toledano MB,Wei Q
Fri Sep 28 00:00:00 EDT 2018
Global analysis of erythroid cells redox status reveals the involvement of Prdx1 and Prdx2 in the severity of beta thalassemia.
PloS one
Romanello KS,Teixeira KKL,Silva JPMO,Nagamatsu ST,Bezerra MAC,Domingos IF,Martins DAP,Araujo AS,Lanaro C,Breyer CA,Ferreira RA,Franco-Penteado C,Costa FF,Malavazi I,Netto LES,de Oliveira MA,Cunha AF
Mon May 06 00:00:00 EDT 2019
Global analysis of erythroid cells redox status reveals the involvement of Prdx1 and Prdx2 in the severity of beta thalassemia.
PloS one
Romanello KS,Teixeira KKL,Silva JPMO,Nagamatsu ST,Bezerra MAC,Domingos IF,Martins DAP,Araujo AS,Lanaro C,Breyer CA,Ferreira RA,Franco-Penteado C,Costa FF,Malavazi I,Netto LES,de Oliveira MA,Cunha AF
Mon May 06 00:00:00 EDT 2019
Loss of peroxiredoxin-2 exacerbates eccentric contraction-induced force loss in dystrophin-deficient muscle.
Nature communications
Olthoff JT,Lindsay A,Abo-Zahrah R,Baltgalvis KA,Patrinostro X,Belanto JJ,Yu DY,Perrin BJ,Garry DJ,Rodney GG,Lowe DA,Ervasti JM
Fri Nov 30 00:00:00 EST 2018
Loss of peroxiredoxin-2 exacerbates eccentric contraction-induced force loss in dystrophin-deficient muscle.
Nature communications
Olthoff JT,Lindsay A,Abo-Zahrah R,Baltgalvis KA,Patrinostro X,Belanto JJ,Yu DY,Perrin BJ,Garry DJ,Rodney GG,Lowe DA,Ervasti JM
Fri Nov 30 00:00:00 EST 2018
A clinical drug library screen identifies clobetasol propionate as an NRF2 inhibitor with potential therapeutic efficacy in KEAP1 mutant lung cancer.
Oncogene
Choi EJ,Jung BJ,Lee SH,Yoo HS,Shin EA,Ko HJ,Chang S,Kim SY,Jeon SM
Thu Sep 14 00:00:00 EDT 2017
A clinical drug library screen identifies clobetasol propionate as an NRF2 inhibitor with potential therapeutic efficacy in KEAP1 mutant lung cancer.
Oncogene
Choi EJ,Jung BJ,Lee SH,Yoo HS,Shin EA,Ko HJ,Chang S,Kim SY,Jeon SM
Thu Sep 14 00:00:00 EDT 2017
Sulfiredoxin May Promote Cervical Cancer Metastasis via Wnt/β-Catenin Signaling Pathway.
International journal of molecular sciences
Lan K,Zhao Y,Fan Y,Ma B,Yang S,Liu Q,Linghu H,Wang H
Thu Apr 27 00:00:00 EDT 2017
Sulfiredoxin May Promote Cervical Cancer Metastasis via Wnt/β-Catenin Signaling Pathway.
International journal of molecular sciences
Lan K,Zhao Y,Fan Y,Ma B,Yang S,Liu Q,Linghu H,Wang H
Thu Apr 27 00:00:00 EDT 2017
Sulfiredoxin May Promote Cervical Cancer Metastasis via Wnt/β-Catenin Signaling Pathway.
International journal of molecular sciences
Lan K,Zhao Y,Fan Y,Ma B,Yang S,Liu Q,Linghu H,Wang H
Thu Apr 27 00:00:00 EDT 2017
Sulfiredoxin May Promote Cervical Cancer Metastasis via Wnt/β-Catenin Signaling Pathway.
International journal of molecular sciences
Lan K,Zhao Y,Fan Y,Ma B,Yang S,Liu Q,Linghu H,Wang H
Thu Apr 27 00:00:00 EDT 2017
Thioredoxin system-mediated regulation of mutant Kras associated pancreatic neoplasia and cancer.
Oncotarget
Schultz MA,Diaz AM,Smite S,Lay AR,DeCant B,McKinney R,Mascarinas WE,Xia Y,Neumann C,Bentrem D,Dawson DW,Grippo PJ
Fri Nov 03 00:00:00 EDT 2017
Thioredoxin system-mediated regulation of mutant Kras associated pancreatic neoplasia and cancer.
Oncotarget
Schultz MA,Diaz AM,Smite S,Lay AR,DeCant B,McKinney R,Mascarinas WE,Xia Y,Neumann C,Bentrem D,Dawson DW,Grippo PJ
Fri Nov 03 00:00:00 EDT 2017
Thioredoxin system-mediated regulation of mutant Kras associated pancreatic neoplasia and cancer.
Oncotarget
Schultz MA,Diaz AM,Smite S,Lay AR,DeCant B,McKinney R,Mascarinas WE,Xia Y,Neumann C,Bentrem D,Dawson DW,Grippo PJ
Fri Nov 03 00:00:00 EDT 2017
Thioredoxin system-mediated regulation of mutant Kras associated pancreatic neoplasia and cancer.
Oncotarget
Schultz MA,Diaz AM,Smite S,Lay AR,DeCant B,McKinney R,Mascarinas WE,Xia Y,Neumann C,Bentrem D,Dawson DW,Grippo PJ
Fri Nov 03 00:00:00 EDT 2017
Sulfiredoxin may promote metastasis and invasion of cervical squamous cell carcinoma by epithelial-mesenchymal transition.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Chen X,Lan K,Liu Q,Yang X,Wang H
Wed Mar 01 00:00:00 EST 2017
Sulfiredoxin may promote metastasis and invasion of cervical squamous cell carcinoma by epithelial-mesenchymal transition.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Chen X,Lan K,Liu Q,Yang X,Wang H
Wed Mar 01 00:00:00 EST 2017
Sulfiredoxin may promote metastasis and invasion of cervical squamous cell carcinoma by epithelial-mesenchymal transition.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Chen X,Lan K,Liu Q,Yang X,Wang H
Wed Mar 01 00:00:00 EST 2017
Sulfiredoxin may promote metastasis and invasion of cervical squamous cell carcinoma by epithelial-mesenchymal transition.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Chen X,Lan K,Liu Q,Yang X,Wang H
Wed Mar 01 00:00:00 EST 2017
Myeloperoxidase-Oxidized LDLs Enhance an Anti-Inflammatory M2 and Antioxidant Phenotype in Murine Macrophages.
Mediators of inflammation
Pireaux V,Sauvage A,Bihin B,Van Steenbrugge M,Rousseau A,Van Antwerpen P,Zouaoui Boudjeltia K,Raes M
Wed Nov 20 00:00:00 EST 2019
Myeloperoxidase-Oxidized LDLs Enhance an Anti-Inflammatory M2 and Antioxidant Phenotype in Murine Macrophages.
Mediators of inflammation
Pireaux V,Sauvage A,Bihin B,Van Steenbrugge M,Rousseau A,Van Antwerpen P,Zouaoui Boudjeltia K,Raes M
Wed Nov 20 00:00:00 EST 2019
Intracellular glutathione determines bortezomib cytotoxicity in multiple myeloma cells.
Blood cancer journal
Starheim KK,Holien T,Misund K,Johansson I,Baranowska KA,Sponaas AM,Hella H,Buene G,Waage A,Sundan A,Bjørkøy G
Fri Jul 15 00:00:00 EDT 2016
Intracellular glutathione determines bortezomib cytotoxicity in multiple myeloma cells.
Blood cancer journal
Starheim KK,Holien T,Misund K,Johansson I,Baranowska KA,Sponaas AM,Hella H,Buene G,Waage A,Sundan A,Bjørkøy G
Fri Jul 15 00:00:00 EDT 2016
Dysregulation of redox-state-regulating enzymes in melanocytic skin tumours and the surrounding microenvironment.
Histopathology
Hintsala HR,Soini Y,Haapasaari KM,Karihtala P
Tue Sep 01 00:00:00 EDT 2015
Dysregulation of redox-state-regulating enzymes in melanocytic skin tumours and the surrounding microenvironment.
Histopathology
Hintsala HR,Soini Y,Haapasaari KM,Karihtala P
Tue Sep 01 00:00:00 EDT 2015
Sulfiredoxin-1 protects primary cultured astrocytes from ischemia-induced damage.
Neurochemistry international
Yu S,Wang X,Lei S,Chen X,Liu Y,Zhou Y,Zhou Y,Wu J,Zhao Y
Sun Mar 01 00:00:00 EST 2015
Sulfiredoxin-1 protects primary cultured astrocytes from ischemia-induced damage.
Neurochemistry international
Yu S,Wang X,Lei S,Chen X,Liu Y,Zhou Y,Zhou Y,Wu J,Zhao Y
Sun Mar 01 00:00:00 EST 2015
Sulfiredoxin Promotes Colorectal Cancer Cell Invasion and Metastasis through a Novel Mechanism of Enhancing EGFR Signaling.
Molecular cancer research : MCR
Jiang H,Wu L,Chen J,Mishra M,Chawsheen HA,Zhu H,Wei Q
Tue Dec 01 00:00:00 EST 2015
Tumor promoter-induced sulfiredoxin is required for mouse skin tumorigenesis.
Carcinogenesis
Wu L,Jiang H,Chawsheen HA,Mishra M,Young MR,Gerard M,Toledano MB,Colburn NH,Wei Q
Thu May 01 00:00:00 EDT 2014
Tumor promoter-induced sulfiredoxin is required for mouse skin tumorigenesis.
Carcinogenesis
Wu L,Jiang H,Chawsheen HA,Mishra M,Young MR,Gerard M,Toledano MB,Colburn NH,Wei Q
Thu May 01 00:00:00 EDT 2014
Tumor promoter-induced sulfiredoxin is required for mouse skin tumorigenesis.
Carcinogenesis
Wu L,Jiang H,Chawsheen HA,Mishra M,Young MR,Gerard M,Toledano MB,Colburn NH,Wei Q
Thu May 01 00:00:00 EDT 2014
Tumor promoter-induced sulfiredoxin is required for mouse skin tumorigenesis.
Carcinogenesis
Wu L,Jiang H,Chawsheen HA,Mishra M,Young MR,Gerard M,Toledano MB,Colburn NH,Wei Q
Thu May 01 00:00:00 EDT 2014
Nuclear Nrf2 expression is related to a poor survival in pancreatic adenocarcinoma.
Pathology, research and practice
Soini Y,Eskelinen M,Juvonen P,Kärjä V,Haapasaari KM,Saarela A,Karihtala P
Wed Jan 01 00:00:00 EST 2014
Nuclear Nrf2 expression is related to a poor survival in pancreatic adenocarcinoma.
Pathology, research and practice
Soini Y,Eskelinen M,Juvonen P,Kärjä V,Haapasaari KM,Saarela A,Karihtala P
Wed Jan 01 00:00:00 EST 2014
Loss of sulfiredoxin renders mice resistant to azoxymethane/dextran sulfate sodium-induced colon carcinogenesis.
Carcinogenesis
Wei Q,Jiang H,Baker A,Dodge LK,Gerard M,Young MR,Toledano MB,Colburn NH
Sat Jun 01 00:00:00 EDT 2013
Loss of sulfiredoxin renders mice resistant to azoxymethane/dextran sulfate sodium-induced colon carcinogenesis.
Carcinogenesis
Wei Q,Jiang H,Baker A,Dodge LK,Gerard M,Young MR,Toledano MB,Colburn NH
Sat Jun 01 00:00:00 EDT 2013
Loss of sulfiredoxin renders mice resistant to azoxymethane/dextran sulfate sodium-induced colon carcinogenesis.
Carcinogenesis
Wei Q,Jiang H,Baker A,Dodge LK,Gerard M,Young MR,Toledano MB,Colburn NH
Sat Jun 01 00:00:00 EDT 2013
Loss of sulfiredoxin renders mice resistant to azoxymethane/dextran sulfate sodium-induced colon carcinogenesis.
Carcinogenesis
Wei Q,Jiang H,Baker A,Dodge LK,Gerard M,Young MR,Toledano MB,Colburn NH
Sat Jun 01 00:00:00 EDT 2013
Genetic polymorphisms and protein expression of NRF2 and Sulfiredoxin predict survival outcomes in breast cancer.
Cancer research
Hartikainen JM,Tengström M,Kosma VM,Kinnula VL,Mannermaa A,Soini Y
Thu Nov 01 00:00:00 EDT 2012
Genetic polymorphisms and protein expression of NRF2 and Sulfiredoxin predict survival outcomes in breast cancer.
Cancer research
Hartikainen JM,Tengström M,Kosma VM,Kinnula VL,Mannermaa A,Soini Y
Thu Nov 01 00:00:00 EDT 2012
Nuclear factor erythroid-derived 2-like 2 (Nrf2) and DJ1 are prognostic factors in lung cancer.
Human pathology
Merikallio H,Pääkkö P,Kinnula VL,Harju T,Soini Y
Sun Apr 01 00:00:00 EDT 2012
Nuclear factor erythroid-derived 2-like 2 (Nrf2) and DJ1 are prognostic factors in lung cancer.
Human pathology
Merikallio H,Pääkkö P,Kinnula VL,Harju T,Soini Y
Sun Apr 01 00:00:00 EDT 2012
Sulfiredoxin-Peroxiredoxin IV axis promotes human lung cancer progression through modulation of specific phosphokinase signaling.
Proceedings of the National Academy of Sciences of the United States of America
Wei Q,Jiang H,Xiao Z,Baker A,Young MR,Veenstra TD,Colburn NH
Tue Apr 26 00:00:00 EDT 2011
Sulfiredoxin-Peroxiredoxin IV axis promotes human lung cancer progression through modulation of specific phosphokinase signaling.
Proceedings of the National Academy of Sciences of the United States of America
Wei Q,Jiang H,Xiao Z,Baker A,Young MR,Veenstra TD,Colburn NH
Tue Apr 26 00:00:00 EDT 2011
Sulfiredoxin-Peroxiredoxin IV axis promotes human lung cancer progression through modulation of specific phosphokinase signaling.
Proceedings of the National Academy of Sciences of the United States of America
Wei Q,Jiang H,Xiao Z,Baker A,Young MR,Veenstra TD,Colburn NH
Tue Apr 26 00:00:00 EDT 2011
Sulfiredoxin-Peroxiredoxin IV axis promotes human lung cancer progression through modulation of specific phosphokinase signaling.
Proceedings of the National Academy of Sciences of the United States of America
Wei Q,Jiang H,Xiao Z,Baker A,Young MR,Veenstra TD,Colburn NH
Tue Apr 26 00:00:00 EDT 2011
Cell-specific elevation of NRF2 and sulfiredoxin-1 as markers of oxidative stress in the lungs of idiopathic pulmonary fibrosis and non-specific interstitial pneumonia.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica
Mazur W,Lindholm P,Vuorinen K,Myllärniemi M,Salmenkivi K,Kinnula VL
Wed Sep 01 00:00:00 EDT 2010
Cell-specific elevation of NRF2 and sulfiredoxin-1 as markers of oxidative stress in the lungs of idiopathic pulmonary fibrosis and non-specific interstitial pneumonia.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica
Mazur W,Lindholm P,Vuorinen K,Myllärniemi M,Salmenkivi K,Kinnula VL
Wed Sep 01 00:00:00 EDT 2010
Cell-specific elevation of NRF2 and sulfiredoxin-1 as markers of oxidative stress in the lungs of idiopathic pulmonary fibrosis and non-specific interstitial pneumonia.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica
Mazur W,Lindholm P,Vuorinen K,Myllärniemi M,Salmenkivi K,Kinnula VL
Wed Sep 01 00:00:00 EDT 2010
Cell-specific elevation of NRF2 and sulfiredoxin-1 as markers of oxidative stress in the lungs of idiopathic pulmonary fibrosis and non-specific interstitial pneumonia.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica
Mazur W,Lindholm P,Vuorinen K,Myllärniemi M,Salmenkivi K,Kinnula VL
Wed Sep 01 00:00:00 EDT 2010
